← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

A

$ Value

$0

Shares

59,372

Price

$0

Filed

Jan 9

Insider

Name

Garland J. Scott

Title

CIK

0001533228

Roles

Director

Transaction Details

Transaction Date

2026-01-07

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

59,372

Footnotes

1/36th of the shares subject to the option will vest on February 7, 2026 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.

Filing Info

Accession No.

0001533228-26-000002

Form Type

4

Issuer CIK

0001672619

Garland J. Scott's History

Date Ticker Type Value
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-02-12 ELVN A $0
2026-01-20 ALXO A $0
2026-01-07 ELVN A $0
2025-11-06 DAWN D $0

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.2M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$296K 2026-03-06
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12